MyAverix Finance
SHG · Healthcare
Qinghai Spring Medicinal Resources Technology Co Ltd (600381)
Drug Manufacturers - Specialty & Generic
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $1.68B, P/E ratio is 18.00, net margin is -39.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600381
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — FAQ
What is Qinghai Spring Medicinal Resources Technology Co Ltd's market cap?
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a reported market cap of $1.68B (data as of 2026-03-28).
What is 600381's P/E ratio?
The price-to-earnings (P/E) ratio for Qinghai Spring Medicinal Resources Technology Co Ltd (600381) is 18.00 (data as of 2026-03-28).
Does Qinghai Spring Medicinal Resources Technology Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Qinghai Spring Medicinal Resources Technology Co Ltd (600381). Check the MyAverix Finance app for the latest dividend data.
What sector is Qinghai Spring Medicinal Resources Technology Co Ltd in?
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600381 listed on?
600381 is listed on SHG.
What is Qinghai Spring Medicinal Resources Technology Co Ltd's net margin?
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) reports a net margin of -39.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.